The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Tumour heterogeneity in oesophageal cancer assessed by CT texture analysis: Preliminary evidence of an association with tumour metabolism, stage, and survival
Open accessAbstract
AIM To undertake a pilot study assessing whether tumour heterogeneity evaluated using computed tomography texture analysis (CTTA) has the potential to provide a marker of tumour aggression and prognosis in oesophageal cancer. MATERIALS AND METHODS In 21 patients, unenhanced CT images of the primary oesophageal lesion obtained using positron-emission tomography (PET)-CT examinations underwent CTTA. CTTA was carried out using a software algorithm that selectively filters and extracts textures at different anatomical scales between filter values 1.0 (fine detail) and 2.5 (coarse features) with quantification as entropy and uniformity (measures image heterogeneity). Texture parameters were correlated with average tumour 2-[(18)F]-fluoro-2-deoxy-d-glucose (FDG) uptake [standardized uptake values (SUV(mean) and SUV(max))] and clinical staging as determined by endoscopic ultrasound (nodal involvement) and PET-CT (distant metastases). The relationship between tumour stage, FDG uptake, and texture with survival was assessed using Kaplan-Meier analysis. RESULTS Tumour heterogeneity correlated with SUV(max) and SUV(mean). The closest correlations were found for SUV(mean) measured as uniformity and entropy with coarse filtration (r=-0.754, p<0.0001; and r=0.748, p=0.0001 respectively). Heterogeneity was also significantly greater in patients with clinical stage III or IV for filter values between 1.0 and 2.0 (maximum difference at filter value 1.5: entropy: p=0.027; uniformity p=0.032). The median (range) survival was 21 (4-34) months. Tumour heterogeneity assessed by CTTA (coarse uniformity) was an independent predictor of survival [odds ratio (OR)=4.45 (95% CI: 1.08, 18.37); p=0.039]. CONCLUSION CTTA assessment of tumour heterogeneity has the potential to identify oesophageal cancers with adverse biological features and provide a prognostic indicator of survival.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stewart, B. W., & Kleihues, P. (2003) · Cited by 2,386
HIF-1 and tumor progression: pathophysiology and therapeutics
Semenza, G. L. (2002) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(02)02317-1 · Cited by 1,060
Ganeshan, B., Abaleke, S., Young, R. C. D., Chatwin, C. R., & Miles, K. A. (2010) · Cancer Imaging · doi:10.1102/1470-7330.2010.0021 · Cited by 324
Self-citationHypoxia and defective apoptosis drive genomic instability and tumorigenesis
Nelson, D. A., Tan, T.-T., Rabson, A. B., Anderson, D., Degenhardt, K., & White, E. (2004) · Genes & Development · doi:10.1101/gad.1204904 · Cited by 281
Miles, K. A., Ganeshan, B., Griffiths, M. R., Young, R. C. D., & Chatwin, C. R. (2009) · Radiology · doi:10.1148/radiol.2502071879 · Cited by 253
Self-citationVessel abnormalization: another hallmark of cancer?
De Bock, K., Cauwenberghs, S., & Carmeliet, P. (2011) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2010.10.008 · Cited by 213
Pan, L., Gu, P., Huang, G., Xue, H., & Wu, S. (2009) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e328323d6fa · Cited by 140
Imaging in Oncology, Second Edition
(2004) · CRC Press eBooks · doi:10.3109/9780203421314 · Cited by 113
Cerfolio, R. J., & Bryant, A. S. (2006) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2006.03.045 · Cited by 108
Ganeshan, B., Miles, K. A., Young, R. C. D., & Chatwin, C. R. (2007) · Clinical Radiology · doi:10.1016/j.crad.2007.03.004 · Cited by 87
Self-citation2-Deoxy-2-[18F] fluoro-D-glucose uptake and correlation to intratumoral heterogeneity.
Henriksson, E., Kjellén, E., Wahlberg, P., Ohlsson, T. G., Wennerberg, J. P., & Brun, E. (2007) · PubMed · Cited by 73
Donahue, M. J., Blakeley, J. O., Zhou, J., Pomper, M. G., Laterra, J., & van Zijl, P. C. M. (2008) · Magnetic Resonance in Medicine · doi:10.1002/mrm.21467 · Cited by 56
Roedl, J. B., Halpern, E. F., Colen, R. R., Sahani, D. V., Fischman, A. J., & Blake, M. A. (2008) · Molecular Imaging and Biology · doi:10.1007/s11307-008-0169-9 · Cited by 55
Sabo, E., Beck, A. H., Montgomery, E. A., Bhattacharya, B., Meitner, P. A., Wang, J. Y., & Resnick, M. B. (2006) · Laboratory Investigation · doi:10.1038/labinvest.3700481 · Cited by 53
Ganeshan, B., Miles, K. A., Young, R. C. D., Chatwin, C. R., Gurling, H., & Critchley, H. (2009) · European Radiology · doi:10.1007/s00330-009-1605-1 · Cited by 32
Self-citationThree-Dimensional Selective-Scale Texture Analysis of Computed Tomography Pulmonary Angiograms
Ganeshan, B., Miles, K. A., Young, R. C. D., et al. (2008) · Investigative Radiology · doi:10.1097/rli.0b013e3181690091 · Cited by 31
Self-citation
Cited by
Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach
Aerts, H. J. W. L., Velazquez, E. R., Leijenaar, R. T. H., Parmar, C., Grossmann, P., Carvalho, S., Bussink, J., Monshouwer, R., Haibe-Kains, B., Rietveld, D., et al. (2014) · Nature Communications · doi:10.1038/ncomms5006 · Cited by 5,132
Applications and limitations of radiomics
Yip, S. S. F., & Aerts, H. J. W. L. (2016) · Physics in Medicine and Biology · doi:10.1088/0031-9155/61/13/r150 · Cited by 1,210
Assessment of tumor heterogeneity: an emerging imaging tool for clinical practice?
Davnall, F., Yip, C. S. P., Ljungqvist, G., Selmi, M., Ng, F., Sanghera, B., Ganeshan, B., Miles, K. A., Cook, G. J., & Goh, V. (2012) · Insights into Imaging · doi:10.1007/s13244-012-0196-6 · Cited by 878
Self-citationCT Texture Analysis: Definitions, Applications, Biologic Correlates, and Challenges
Lubner, M. G., Smith, A. D., Sandrasegaran, K., Sahani, D. V., & Pickhardt, P. J. (2017) · RadioGraphics · doi:10.1148/rg.2017170056 · Cited by 773
Quantifying tumour heterogeneity in 18F-FDG PET/CT imaging by texture analysis
Chicklore, S., Goh, V., Siddique, M., Roy, A., Marsden, P. K., & Cook, G. J. R. (2013) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-012-2247-0 · Cited by 488
Metadata
- Authors
- Ganeshan, B., Skogen, K., Pressney, I., Coutroubis, D., & Miles, K.
- Venue
- Clinical Radiology
- Publisher
- Elsevier BV
- Published
- 2012-02
- Volume
- 67
- Issue
- 2
- Pages
- 157-164
- ISSN
- 0009-9260 (ISSN-L)
- OpenAlex
- W1965797467
- Cited by
- 310
- References
- 16
- FWCI
- 8.04
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.